Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease [NA]

View source ↗

Summary

A clinical trial evaluating a potassium-containing salt substitute for patients with end-stage kidney disease on hemodialysis; the study status is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium-containing salt substitute

Snippet

Sponsor: NYU Langone Health | Conditions: End Stage Kidney Disease | NA | Status: NOT_YET_RECRUITING